{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T22:02:37Z","timestamp":1784930557185,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004035","name":"Jordan University of Science and Technology","doi-asserted-by":"publisher","award":["306\/2022"],"award-info":[{"award-number":["306\/2022"]}],"id":[{"id":"10.13039\/501100004035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007776","name":"Deanship of Academic Research, University of Jordan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007776","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.heliyon.2023.e19288","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T12:20:59Z","timestamp":1692706859000},"page":"e19288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Knowledge, awareness, and attitude among pharmacists regarding the risk estimation of cardiovascular disease in Jordan: Immersion of lipid-lowering agents"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4619-2012","authenticated-orcid":false,"given":"Abeer M.","family":"Rababa'h","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6730-889X","authenticated-orcid":false,"given":"Mera","family":"Ababneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nour N.","family":"Abedalqader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salah Eldien","family":"Altarabsheh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.heliyon.2023.e19288_bib1","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/CIRCRESAHA.117.308903","article-title":"Reducing the global burden of cardiovascular disease, Part 1: the epidemiology and risk factors","volume":"121","author":"Joseph","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.heliyon.2023.e19288_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2021.106791","article-title":"Heart disease: the forgotten pandemic","volume":"153","author":"DuBroff","year":"2021","journal-title":"Prev. Med."},{"issue":"1 Suppl","key":"10.1016\/j.heliyon.2023.e19288_bib3","doi-asserted-by":"crossref","first-page":"3A","DOI":"10.1016\/j.amjcard.2009.10.007","article-title":"Cardiovascular disease risk factors: epidemiology and risk assessment","volume":"105","author":"Dahlof","year":"2010","journal-title":"Am. J. Cardiol."},{"issue":"25","key":"10.1016\/j.heliyon.2023.e19288_bib4","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: Update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e19288_bib6","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1311890","article-title":"Cardiovascular risk and events in 17 low-, middle-, and high-income countries","volume":"371","author":"Yusuf","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.heliyon.2023.e19288_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19148282","article-title":"The cardiovascular disease (CVD) risk continuum from prenatal life to adulthood: a literature review","volume":"19","author":"Faienza","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"10046","key":"10.1016\/j.heliyon.2023.e19288_bib8","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0140-6736(16)30506-2","article-title":"Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study","volume":"388","author":"O'Donnell","year":"2016","journal-title":"Lancet"},{"issue":"9438","key":"10.1016\/j.heliyon.2023.e19288_bib9","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2023.e19288_bib10","series-title":"Global Health Risks : Mortality and Burden of Disease Attributable to Selected Major Risks","year":"2009"},{"key":"10.1016\/j.heliyon.2023.e19288_bib11","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.amsu.2020.09.036","article-title":"Distance education during the COVID-19 outbreak: a cross-sectional study among medical students in North of Jordan","volume":"59","author":"Sindiani","year":"2020","journal-title":"Ann. Med. Surg. (Lond)"},{"issue":"25","key":"10.1016\/j.heliyon.2023.e19288_bib12","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1161\/CIRCULATIONAHA.106.655688","article-title":"The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease)","volume":"114","author":"Dzau","year":"2006","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.heliyon.2023.e19288_bib13","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1177\/2047487314543074","article-title":"Calculated and perceived cardiovascular risk in asymptomatic subjects submitted to a routine medical evaluation: the perception gap","volume":"22","author":"Katz","year":"2015","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e19288_bib14","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.numecd.2020.12.032","article-title":"The effects of foods on LDL cholesterol levels: a systematic review of the accumulated evidence from systematic reviews and meta-analyses of randomized controlled trials","volume":"31","author":"Schoeneck","year":"2021","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.heliyon.2023.e19288_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6298739","article-title":"The prevalence of dyslipidemia among Jordanians","volume":"2018","author":"Abujbara","year":"2018","journal-title":"J Lipids"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e19288_bib16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.gheart.2018.09.511","article-title":"Global atlas of cardiovascular disease 2000-2016: the Path to prevention and control","volume":"13","author":"Thomas","year":"2018","journal-title":"Glob. Heart"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e19288_bib17","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1007\/s12350-019-01642-x","article-title":"Cardiovascular risk assessment models: have we found the perfect solution yet?","volume":"27","author":"Abidov","year":"2020","journal-title":"J. Nucl. Cardiol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e19288_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047681","article-title":"Contemporary management and attainment of cholesterol targets for patients with dyslipidemia in China","volume":"8","author":"Gao","year":"2013","journal-title":"PLoS One"},{"issue":"9753","key":"10.1016\/j.heliyon.2023.e19288_bib19","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Cholesterol Treatment Trialists","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19288_bib20","article-title":"Treatment strategy for dyslipidemia in cardiovascular disease prevention: Focus on old and new drugs","volume":"6","author":"Zodda","year":"2018","journal-title":"Pharmacy (Basel)"},{"key":"10.1016\/j.heliyon.2023.e19288_bib21","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijcard.2016.11.048","article-title":"Comparison of cardiovascular risk assessment tools and their guidelines in evaluation of 10-year CVD risk and preventive recommendations: a population based study","volume":"228","author":"Motamed","year":"2017","journal-title":"Int. J. Cardiol."},{"issue":"25 Pt B","key":"10.1016\/j.heliyon.2023.e19288_bib22","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American heart association Task Force on practice guidelines","volume":"63","author":"Goff","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e19288_bib23","first-page":"e563","article-title":"ACC\/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology\/American heart association Task Force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e19288_bib24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/1074248413492906","article-title":"Lipid-lowering agents","volume":"18","author":"Ewang-Emukowhate","year":"2013","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e19288_bib25","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1001\/jama.2022.13044","article-title":"Statin use for the primary prevention of cardiovascular disease in adults: US preventive Services Task Force recommendation statement","volume":"328","author":"Force","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.heliyon.2023.e19288_bib26","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2147\/IJGM.S160555","article-title":"Expert opinion on the applicability of dyslipidemia guidelines in Asia and the Middle East","volume":"11","author":"Alshamiri","year":"2018","journal-title":"Int. J. Gen. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19288_bib27","first-page":"124","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"15","year":"2004","journal-title":"J. Int. Bioethique"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e19288_bib28","article-title":"Evaluation of physician's knowledge in Jordan about the ACC\/AHA blood cholesterol guidelines","volume":"75","author":"Rababa'h","year":"2021","journal-title":"Int. J. Clin. Pract."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e19288_bib29","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/03007995.2021.1994380","article-title":"Knowledge, attitude, perceived barriers, and practices among pharmacists regarding risk assessment of cardiovascular disease: a cross-sectional study in Yemen","volume":"38","author":"Al-Ashwal","year":"2022","journal-title":"Curr. Med. Res. Opin."},{"issue":"25","key":"10.1016\/j.heliyon.2023.e19288_bib30","doi-asserted-by":"crossref","first-page":"e1144","DOI":"10.1161\/CIR.0000000000000626","article-title":"Systematic review for the 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American heart association Task Force on clinical practice guidelines","volume":"139","author":"Wilson","year":"2019","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e19288_bib31","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.2042-7174.2012.00208.x","article-title":"Public knowledge and awareness of cardiovascular disease and its risk factors: a cross-sectional study of 1000 Jordanians","volume":"20","author":"Mukattash","year":"2012","journal-title":"Int. J. Pharm. Pract."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e19288_bib32","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jacl.2017.11.010","article-title":"Clinical pharmacist understanding of the 2013 American College of Cardiology\/American heart association cholesterol guideline","volume":"12","author":"Bucheit","year":"2018","journal-title":"J. Clin. Lipidol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023064964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023064964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T21:15:09Z","timestamp":1784927709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023064964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2405844023064964"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e19288","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Knowledge, awareness, and attitude among pharmacists regarding the risk estimation of cardiovascular disease in Jordan: Immersion of lipid-lowering agents","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e19288","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e19288"}}